22.60
price down icon5.99%   -1.44
pre-market  시장 영업 전:  22.89   0.29   +1.28%
loading
전일 마감가:
$24.04
열려 있는:
$24.1
하루 거래량:
2.09M
Relative Volume:
2.14
시가총액:
$2.31B
수익:
-
순이익/손실:
$-804.34M
주가수익비율:
-2.4017
EPS:
-9.41
순현금흐름:
$-531.06M
1주 성능:
-24.34%
1개월 성능:
-39.21%
6개월 성능:
-53.47%
1년 성능:
-56.59%
1일 변동 폭
Value
$21.68
$24.21
1주일 범위
Value
$21.47
$30.21
52주 변동 폭
Value
$21.47
$55.72

바이오헤이븐 Stock (BHVN) Company Profile

Name
명칭
Biohaven Ltd
Name
전화
203-404-0410
Name
주소
215 CHURCH STREET, NEW HAVEN, CT
Name
직원
256
Name
트위터
@biohavenpharma
Name
다음 수익 날짜
2022-11-07T13:30:00.000Z
Name
최신 SEC 제출 서류
Name
BHVN's Discussions on Twitter

BHVN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
BHVN
Biohaven Ltd
22.60 2.31B 0 -804.34M -531.06M -9.41
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

바이오헤이븐 Stock (BHVN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-11 개시 Deutsche Bank Buy
2024-09-16 개시 Jefferies Buy
2024-09-04 개시 Bernstein Outperform
2024-07-24 개시 Morgan Stanley Overweight
2024-02-16 개시 RBC Capital Mkts Outperform
2024-02-06 개시 UBS Buy
2023-12-22 개시 H.C. Wainwright Buy
2023-12-08 개시 Robert W. Baird Outperform
2023-01-24 개시 SVB Securities Outperform
2023-01-04 개시 JP Morgan Overweight
2022-12-02 개시 BTIG Research Buy
2022-10-26 업그레이드 Cantor Fitzgerald Neutral → Overweight
2022-10-12 개시 Piper Sandler Overweight
2022-08-19 다운그레이드 Piper Sandler Overweight → Neutral
2022-08-08 다운그레이드 Wedbush Outperform → Neutral
2022-05-11 다운그레이드 SVB Leerink Outperform → Mkt Perform
2021-10-19 재개 Morgan Stanley Equal-Weight
2021-08-10 다운그레이드 UBS Buy → Neutral
2021-08-03 재확인 Canaccord Genuity Buy
2021-03-11 개시 UBS Buy
2020-12-15 개시 H.C. Wainwright Buy
2020-04-17 개시 Cowen Outperform
2020-02-10 다운그레이드 Oppenheimer Outperform → Perform
2020-02-06 개시 Mizuho Buy
2019-11-22 개시 Wedbush Outperform
2019-06-25 재확인 Canaccord Genuity Buy
2019-05-06 개시 Goldman Buy
2019-04-09 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2019-03-04 재확인 Needham Buy
2018-07-03 재확인 Needham Buy
2018-07-02 재확인 Needham Buy
2018-04-05 다운그레이드 Barclays Overweight → Equal Weight
2018-02-22 재확인 Canaccord Genuity Buy
2017-12-15 개시 Canaccord Genuity Buy
2017-10-03 재확인 Needham Buy
모두보기

바이오헤이븐 주식(BHVN)의 최신 뉴스

pulisher
Apr 01, 2025

American Century Companies boosts stake in Biohaven, ETF Daily News says - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biohaven LtdBHVN - PR Newswire

Mar 31, 2025
pulisher
Mar 31, 2025

Biohaven Ltd. Shares Tumble Amid Market Reassessment - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Biohaven Ltd. (NYSE:BHVN) Shares Bought by American Century Companies Inc. - Defense World

Mar 31, 2025
pulisher
Mar 30, 2025

Teacher Retirement System of Texas Raises Stake in Biohaven Ltd. (NYSE:BHVN) - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

(BHVN) Proactive Strategies - Stock Traders Daily

Mar 29, 2025
pulisher
Mar 28, 2025

Biohaven stock hits 52-week low at $26.7 amid market challenges By Investing.com - Investing.com South Africa

Mar 28, 2025
pulisher
Mar 28, 2025

Biohaven stock hits 52-week low at $26.7 amid market challenges - Investing.com India

Mar 28, 2025
pulisher
Mar 28, 2025

Biohaven (BHVN) Stock Price, News & Analysis - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

Emerald Advisers LLC Acquires New Holdings in Biohaven Ltd. (NYSE:BHVN) - MarketBeat

Mar 27, 2025
pulisher
Mar 25, 2025

Focal Epilepsy Market: Analysis of Epidemiology, Pipeline - openPR

Mar 25, 2025
pulisher
Mar 22, 2025

Biohaven Ltd. (NYSE:BHVN) Shares Sold by Amundi - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Major Player in the Multiple System Atrophy (MSA) Market - openPR

Mar 21, 2025
pulisher
Mar 20, 2025

Multiple System Atrophy Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Ionis Pharma - Barchart

Mar 20, 2025
pulisher
Mar 20, 2025

Multiple System Atrophy Market to Reach New Heights in Growth - openPR

Mar 20, 2025
pulisher
Mar 20, 2025

Immunovant data positive for Biohaven, says Deutsche Bank - TipRanks

Mar 20, 2025
pulisher
Mar 19, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Shareholders to Learn More About the Investigation - Markets Insider

Mar 19, 2025
pulisher
Mar 19, 2025

How To Trade (BHVN) - Stock Traders Daily

Mar 19, 2025
pulisher
Mar 18, 2025

Biohaven’s 47% decline validates InvestingPro’s bearish Fair Value call By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

SEC Form DEF 14A filed by Biohaven Ltd. - Quantisnow

Mar 18, 2025
pulisher
Mar 18, 2025

Spinocerebellar Ataxias Pipeline 2025: Therapies, MOA - openPR

Mar 18, 2025
pulisher
Mar 18, 2025

Charles Schwab Investment Management Inc. Increases Stock Holdings in Biohaven Ltd. (NYSE:BHVN) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Biohaven Ltd. Being Investigated on Behalf of Biohaven Ltd. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

US Bancorp DE Raises Stock Position in Biohaven Ltd. (NYSE:BHVN) - Defense World

Mar 17, 2025
pulisher
Mar 16, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Shareholders to Connect - Markets Insider

Mar 16, 2025
pulisher
Mar 16, 2025

Biohaven Ltd. Under Investigation: Levi & Korsinsky Probes Potential Securities Violations - Apna Kal

Mar 16, 2025
pulisher
Mar 15, 2025

Investors who lost money on Biohaven Ltd. should contact Levi & Korsinsky about an ongoing investigationBHVN - ACCESS Newswire

Mar 15, 2025
pulisher
Mar 14, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Biohaven Ltd. (BHVN) And Encourages Investors to Connect - Markets Insider

Mar 14, 2025
pulisher
Mar 14, 2025

Biohaven Ltd. (NYSE:BHVN) Shares Bought by Bank of New York Mellon Corp - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Unpartnered Obesity Assets Are Becoming Slim Pickings For Pharma - Citeline News & Insights

Mar 13, 2025
pulisher
Mar 13, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Stockholders to Inquire about Securities Investigation - Markets Insider

Mar 13, 2025
pulisher
Mar 12, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Investors to Learn More About the Investigation - Markets Insider

Mar 12, 2025
pulisher
Mar 12, 2025

Biohaven Ltd. (NYSE:BHVN) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Biohaven Ltd. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Biohaven Ltd. (BHVN) - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 11, 2025

Biohaven Ltd. (BHVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider

Mar 11, 2025
pulisher
Mar 10, 2025

ATTENTION Biohaven Ltd. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 10, 2025

Positive Outlook for Biohaven Ltd. Amid Promising Developments and FDA Priority Review - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Independent Director of Biohaven John Childs Buys More Stock - Simply Wall St

Mar 10, 2025
pulisher
Mar 09, 2025

Biohaven Ltd. (BHVN): Among Stocks with Heavy Insider Buying in 2025 - Insider Monkey

Mar 09, 2025
pulisher
Mar 09, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biohaven Ltd. (BHVN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider

Mar 09, 2025
pulisher
Mar 09, 2025

Biohaven Ltd. Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsBHVN - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 09, 2025

Morgan Stanley Lowers Biohaven (NYSE:BHVN) Price Target to $63.00 - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

How to Take Advantage of moves in (BHVN) - Stock Traders Daily

Mar 08, 2025
pulisher
Mar 08, 2025

Empowering women in STEM: Navigating CMC regulatory affairs -March 08, 2025 at 04:31 am EST - Marketscreener.com

Mar 08, 2025
pulisher
Mar 07, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Biohaven Ltd. (BHVN) Investors to Inquire about Securities Investigation - markets.businessinsider.com

Mar 07, 2025
pulisher
Mar 07, 2025

Biohaven price target lowered to $63 from $69 at Morgan Stanley - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Piper Sandler maintains Biohaven stock with $76 target - Investing.com India

Mar 07, 2025
pulisher
Mar 07, 2025

Biohaven Ltd. (NYSE:BHVN) Shares Sold by Private Advisor Group LLC - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

JPMorgan Chase & Co. Lowers Biohaven (NYSE:BHVN) Price Target to $68.00 - Defense World

Mar 07, 2025
pulisher
Mar 07, 2025

Biohaven FY2025 EPS Forecast Reduced by Cantor Fitzgerald - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

Morgan Stanley cuts Biohaven stock price target to $63 from $69 By Investing.com - Investing.com South Africa

Mar 06, 2025

바이오헤이븐 (BHVN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
자본화:     |  볼륨(24시간):